Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2013 036 167.3 |
96 | EP file number | EAKZ | 13 80 0681.2 |
86 | WO file number | WAKZ | PCT/US2013/044116 |
97 | EP publication number | EPN | 2858985 |
87 | WO publication number | WPN | 2013184681 |
54 | Designation/title | TI | KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS |
51 | IPC main class | ICM (ICMV) | C07D 401/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/4439 (2006.01), A61K 31/4184 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Jun 4, 2013 |
96 | EP application date | EAT | Jun 4, 2013 |
86 | WO application date | WAT | Jun 4, 2013 |
43 | Date of first publication | OT | Dec 12, 2013 |
| Date of publication of grant | PET | Apr 18, 2018 |
71/73 | Applicant/owner | INH | Aragon Pharmaceuticals, Inc., San Diego, Calif., US; Sloan-Kettering Institute for Cancer Research, New York, N.Y., US |
72 | Inventor | IN | SMITH, Nicholas, D., San Diego, CA 92109, US; HERBERT, Mark, R., San Diego, CA 92111, US; OUERFELLI, Ouathek, Fort Lee, NJ 07024, US; DILHAS, Anna, 4055 Basel, CH |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261656888 P Jun 7, 2012
|
| Due date | FT FG | Jun 30, 2025 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document: EP000002858985 Searchable text:
EP000002858985 Original document:
EP000002858985B1 Searchable text:
EP000002858985B1 Original document:
WO002013184681 Searchable text:
WO002013184681 |
43 | Date of first publication | EVT | Dec 12, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Apr 16, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 19, 2024 (Show all update days)(Hide all update days)- Sep 19, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 14.05.2024: changed
- Aug 15, 2024
- Procedures: Opposition procedure, Patent maintained in full by EPO, 14.05.2024: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in full has become final, 14.05.2024: new
- Jul 9, 2024; May 14, 2024; May 10, 2023; May 14, 2022; May 18, 2021; May 26, 2020; Aug 17, 2019; May 30, 2019; Mar 14, 2019; Feb 7, 2019; Jun 6, 2018; May 17, 2018; Apr 11, 2018; Apr 5, 2018; Aug 10, 2017
- Historical data not available for this/these date(s)
- Apr 16, 2015
- Date of the first transfer into DPMAregister
|